The Independent Voice of
European Private Equity

Advanced Search

Vendis Capital grabs over-the-counter pharmaceuticals business Sylphar

Lucy White 16 May 2017

Consumer brands investor Vendis Capital has taken a stake in Sylphar, an over-the-counter pharmaceuticals company.

Sylphar’s products span the oral beauty and therapy and medicated skincare segments, and its brands include iWhite, Remescar, Herpatch and Shur.

Vendis

Related Articles

VC performance hits new high

23/07/19

Waterland-backed Median makes two deals

23/07/19

LBO France makes investment in Ecritel

23/07/19

Agilitas-backed Hydro makes second bolt-on

23/07/19

Innova Capital buys Optiplaza

23/07/19

Maven invests in computing company ebb3

23/07/19